TABLET WITH THE SLOWED DOWN LIBERATION, CONTAINING A ALFUZOSIN HYDROCHLORIDE Russian patent published in 2012 - IPC A61K9/22 A61K31/517 A61K47/38 A61P13/08 

Abstract RU 2442570 C1

FIELD: medicine.

SUBSTANCE: invention refers namely to pharmaceutical industry, and concerns tablets with the slowed down liberation, containing alfuzosin hydrochloride. The tablet includes: the top layer including 0,2 weight parts of alfuzosin HC1, 90 weight. parts of hypromellose, 29. 6 weight parts of polyethylene oxide, 1 weight part of stearyl alcohol, 0.4 weight parts of easy waterless silicon acid and 1 weight part of ethyl cellulose; and the bottom layer including 9.8 weight parts alfuzosin HC1, 36-62 weight parts of microcrystalline cellulose, 24-60 weight parts of polyethylene oxide, 20 weight parts low substituted hydroxypropyl cellulose, 1-6 weight parts of stearyl alcohol and 99 weights parts of hydroxypropyl cellulose.

EFFECT: received tablet is characterized by the liberation of the medicine with the curve of the zero order.

3 cl, 2 tbl, 10 ex, 6 dwg

Similar patents RU2442570C1

Title Year Author Number
PROLONGED RELEASE TABLET CONTAINING THEOBROMIN 2010
  • Aukh Dzhin
  • Kim Chan-Khvan
  • Khan Chan-Kjun
  • Dzhon Khen-Gun
  • Kim Jan-Dzhoon
  • Kim Dzhon-Gial
  • Eun Dzhu-En
  • Lee Dzhun-Khva
RU2506947C2
STABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING LEVOCETIRIZINE, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND MONTELUKAST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 2013
  • Kvon Taek Kvan
  • Kim Dong Kho
  • Kim Kieong Soo
  • Kim Jong Il
  • Park Dzae Khiun
  • Voo Dzong Soo
RU2614382C2
PHARMACEUTICAL COMPOSITIONS, CONTAINING IMATINIB AND RELEASE MODERATOR 2006
  • Vasantavada Madkhav
  • Lakshman Dzhej Partiban
  • Ton Vehjtsin'
  • Seradzhuddin Abu T.M.
RU2404775C2
COMBINED COMPOSITION CONTAINING METFORMIN OF SUSTAINED RELEASE AND INHIBITOR HMG-CoA-REDUCTASE OF IMMEDIATE RELEASE 2014
  • Kang Kwi Man
  • Park Young Joon
  • Park Jun Hong
  • Lee Ji Eun
  • Yoon Seok Kee
  • Kim Yu Jeong
  • Oh Tack Oon
  • Cho Tae Keun
RU2651460C2
ORAL DOSAGE FORMS OF TOFACITINIB WITH CONTINUOUS RELEASE 2014
  • Kherbig Skott Maks
  • Krishnasvami Srajrem
  • Kushner Iv Dzhozef
  • Lemba Manisha
  • Shtok Tomas Si
RU2790166C2
PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR 2007
  • Ambjul' Mikhaehl'
  • Bejer Jutta
  • Karreno-Gomes Begona
  • R'Jugger Kollin
  • Valazza Stiven
RU2487703C2
HARD, SUITABLE FOR ORAL INTAKE PHARMACEUTICAL FORMS OF APPLICATION, CONTAINING RIVAROXABAN WITH MODIFIED RELEASE 2005
  • Benke Klaus
  • Khenk Jan-Olav
RU2420290C2
COMPOSITION WITH RAPID ONSET EFFECT 2001
  • Gervais Eric
RU2266744C2
GASTRAL RETENTIVE COMPOSITIONS AND ITS PRODUCTION METHODS 2006
  • Chaudkhari Makhendra
  • Chandvani Omprakash D.
  • Jelegaonkar Radzhashri S.
RU2376983C2
PHARMACEUTICAL COMPOSITION 2008
  • Kodzima Masazumi
  • Kuno Josio
  • Nakagami Khiroaki
  • Sagasaki Sindzi
  • Isidokh Koiti
  • Sekiguti Gaku
RU2470637C2

RU 2 442 570 C1

Authors

Aukh Dzhin

Kim Chan-Khvan

Khan Chan-Kjun

Dzhehon Khjon-Gun

Kim Jan-Dzhoon

Kim Dzhon-Gehal

Park Dzhun-Ki

Dates

2012-02-20Published

2010-11-18Filed